Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Filed Mar 18, 2013 · 10-K · 77 days after period end · 0001445305-13-000665
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $1.13M | $1.63M | — |
| Net Income | -$658.75K | -$5.48M | — |
| EPS Diluted | $0.00 | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 18, 2013 · 77 d after period end
